|
CitiHope International, an American PVO, conducted a 4-day training CME TOT workshop in Bishkek, January 24-28, 2004, at the hotel “Pinara” within the framework of the Pharmaceutical Benefit Initiative Program funded by USAID.
This pilot program targets primary health care and empowers 72 family group practice clinics in the Chui, Naryn and Issyk-Kul and Batken Oblasts. The program is focused on humanitarian drugs affordability and accessibility for marginalized population groups through trained family group physicians equipped with essential drugs.
Six highly qualified facilitators from Russia, USA, Belarus and Kyrgyzstan conducted education in clinical pharmacology for 38 trainers of family medicine practitioners within national CME and numerous leading medical specialists and key players in health reform in Kyrgyzstan. Among the lectures were Prof. Leonid Stratchounski - Director of the Institute of Antimicrobial Chemotherapy, and Prof. Vladimir Rafalski - Deputy Director of the Institute of Antimicrobial Chemotherapy, Smolensk, Russia; Prof. Albert Wertheimer, clinical pharmacologist from the Temple University in PA, US; Dr. Golubev - pharmaco-economic specialist from Vitebsk, Belarus, Prof. Zurdinov and Prof. Brimkulov from Kyrgyzstan. Printed lecture materials were provided to all participants as well as books authored by Prof. Stratchounski and Dr. Golubev.
Topics chosen addressed the most urgent need in rural doctors' education and covered rational usage of antibiotics, brucellosis treatment, and non steroid anti inflammatory drags, pharmacoeconomics and others. The audience actively participated in follow-up discussions.
CitiHope International will continue post-graduate clinical pharmacology education as a critical element in proper treatment practices in Kyrgyzstan in 2005. This approach received positive feed back from local medical authorities and health reform champions.
Photos from training
(click an image to enlarge it)
The last modification date: February 2, 2005
4508
CitiHope, workshop, training, Pharmaceutical Benefit Initiative Program, clinical pharmacology, Bishkek | 
